% 100.00% 100.00% Cost of sales (119.80 ) (95.57 ) (24.23 ) 25.35% (74.98%) (68.02%) Gross Profit 39.98 44.94 (4.96 ) (11.04%) 25.02% 31.98% Other income 6.56 6.76 (0.20 ) (2.96%) 4.11% 4.81% Revenues from
litigation (15.86 ) (15.86 ) #DIV/0! (5.36%) 0.00% Reversal of doubtful accounts 0.40 62.94 62.54 99.36% 0.14% 8.88% Finance costs (62.30 ) (36.13 ) 26.17 (72.43%) (21.06%) (5.10%) Tax income (expense) (0.26
(15.86 ) (15.86 ) #N/A (5.36%) 0.00% Reversal of doubtful accounts 0.40 62.94 62.54 99.36% 0.14% 8.88% Finance costs (62.30 ) (36.13 ) 26.17 (72.43%) (21.06%) (5.10%) Tax income (expense) (0.26 ) (9.44
(78.25 ) (35.77%) 100.00% 100.00% Cost of sales (95.57 ) (196.58 ) 101.01 (51.38%) (68.02%) (89.86%) Gross Profit 44.94 22.18 22.76 102.61% 31.98% 10.14% Other income 6.76 6.02 0.74 12.29% 4.81% 2.75
) (35.77%) 100.00% 100.00% Cost of sales (95.57 ) (196.58 ) 101.01 (51.38%) (68.02%) (89.86%) Gross Profit 44.94 22.18 22.76 102.61% 31.98% 10.14% Other income 6.76 6.02 0.74 12.29% 4.81% 2.75% Revenues from
integration of acquired businesses, the start of earning recovery in our high-volume Necessities business and our stable but higher-margin HVA business. We delivered record earnings and cash flows and expect
172 (65%) Core EBITDA Margin(%) 10% 12% 14% (4%) 11% 14% (3%) Integrated PET 10% 13% 13% (3%) 10% 11% (1%) Fibers 6% 8% 7% (1%) 8% 8% 0% Packaging 22% 20% 18% 4% 20% 20% (1%) Integrated Oxides and